title: Effect of thimerosal recommendations on hospitals' neonatal hepatitis B vaccination policies.
abstract: We describe neonatal hepatitis B virus (HBV) vaccine policies in Colorado before and after thimerosal recommendations, plans for use of thimerosal-free HBV vaccine, and nurses' awareness of high-risk criteria for HBV vaccination. The results suggest that fewer neonates are receiving HBV vaccine at birth hospitals.
authors.affiliation: Colorado Rural Immunization Services Project and the Department of Pediatrics, University of Colorado School of Medicine, Denver, USA.
authors.forename: R M
authors.initials: RM
authors.lastname: Brayden
authors.forename: K A
authors.initials: KA
authors.lastname: Pearson
authors.forename: J S
authors.initials: JS
authors.lastname: Jones
authors.forename: B L
authors.initials: BL
authors.lastname: Renfrew
authors.forename: S
authors.initials: S
authors.lastname: Berman
mesh_terms: D002487:Centers for Disease Control and Prevention, U.S.; D019983:Guideline Adherence / Q000592:standards; D006509:Hepatitis B / Q000517:prevention & control; D017325:Hepatitis B Vaccines / Q000009:adverse effects* / Q000627:therapeutic use; D006771:Hospitals, Maternity; D006801:Humans; D007231:Infant, Newborn; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects*; D011634:Public Health; D012307:Risk Factors; D013849:Thimerosal / Q000009:adverse effects*; D014481:United States
chemical_list: D017325:Hepatitis B Vaccines; D011310:Preservatives, Pharmaceutical; D013849:Thimerosal